The Immunological Barriers to Regenerative Medicine (Stem Cell Biology and Regenerative Medicine)

This volume offers an analysis of the scale and nature of the immunological issues facing regenerative medicine, drawing on the expertise of laboratories around the world who have taken up the challenge of applying their expertise in immunology to the vagaries of stem cell biology. In Part I, we explore the extent to which the principles of allograft rejection, learned over several decades from our experiences of whole organ transplantation, apply within the unique context of cell replacement therapy. Part II discusses various innovative ways of addressing the issues of immunogenicity, while, in Part III, we focus exclusively on the induction of immunological tolerance through a variety of novel approaches. It is our hope that this systematic analysis of the current state of the field will galvanise efforts to solve an issue which has so far remained intractable. Recent years have witnessed numerous advances in stem cell research that have suggested novel strategies for the treatment of the chronic and regenerative diseases that pose a growing challenge to the provision of healthcare in the 21st century. Nevertheless, there is little doubt that related disciplines have failed to keep pace with such developments, of which the immunology of transplant rejection is perhaps the most relevant to the nascent field of regenerative medicine. Indeed, given that after decades of research into the mechanisms of organ allograft rejection, we remain wholly dependent on immune suppression to ensure acceptance of foreign tissues, we might legitimately ask whether there is any reason why tissues differentiated from stem cells might not suffer the same fate. This volume seeks to address this issue by drawing on the principles of alloantigen recognition to assess the validity of early convictions that embryonic stem cell-derived tissues may prove invisible to the immune system of the host and the more recent belief that induced pluripotent stem cells, derived in a fully autologous manner, will circumvent the issue of immunogenicity. Having debunked such assumptions and established the magnitude of the immunological barriers to be overcome, this book then draws on the expertise of internationally-recognised laboratories around the world to provide a critical assessment of the likely success of applying strategies such as stem cell banking, silencing of genes that confer immunogenicity, and the induction of transplantation tolerance to overcoming the immunological barriers in the future. Indeed, it is only through reaching a consensus in the field that enduring solutions to such an intractable problem may ultimately emerge. Front Matter....Pages i-xiii Front Matter....Pages 1-1 Mechanisms of Immune Rejection of Stem Cell-Derived Tissues: Insights From Organ Transplantation....Pages 3-36 The Immunogenicity of Embryonic Stem Cells and Their Differentiated Progeny....Pages 37-48 Interaction of Embryonic Stem Cells with the Immune System....Pages 49-67 The Role of NK Cells and T Cells in the Rejection of Embryonic Stem Cell-Derived Tissues....Pages 69-76 Mitigating the Risk of Immunogenicity in the Pursuit of Induced Pluripotency....Pages 77-94 Thymic Involution: A Barrier or Opportunity for Cell Replacement Therapy?....Pages 95-108 Front Matter....Pages 109-109 Construction of Human Embryonic Stem Cell Banks: Prospects for Tissue Matching....Pages 111-128 Generation of Histocompatible Tissues via Parthenogenesis....Pages 129-146 Prospects for Designing ‘Universal’ Stem Cell Lines....Pages 147-173 The Immunosuppressive Properties of Adult Stem Cells: Mesenchymal Stem Cells as a Case Study....Pages 175-197 Front Matter....Pages 199-199 The Immunogenicity of Stem Cells and Thymus-Based Strategies to Minimise Immune Rejection....Pages 201-223 The Induction of Mixed Chimerism Using ES Cell-Derived Hematopoietic Stem Cells....Pages 225-255 Prospects for the Induction of Transplant Tolerance Using Dendritic Cells....Pages 257-278 Strategies for the Induction of Tolerance with Monoclonal Antibodies....Pages 279-295 Induction of Immunological Tolerance to Transgene Products....Pages 297-311 Addressing the Challenge of Autoimmunity in the Treatment of Diabetes with Stem Cells....Pages 313-329 Back Matter....Pages 331-334